Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $883.82M.
ENTERPRISE VALUE (EV)
$883.82M
Corvus Pharmaceuticals, Inc.
Market Cap
$887.99M
Enterprise Value (EV)
$883.82M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Corvus Pharmaceuticals, Inc. (CRVS) | $887.99M | $883.82M |
| Bioventus Inc. (BVS)vs › | $887.50M | $1.12B |
| Arbutus Biopharma Corp (ABUS)vs › | $884.97M | $869.42M |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $870.81M | $813.60M |
| SI-BONE, Inc. (SIBN)vs › | $867.03M | $841.07M |
| HealthStream, Inc. (HSTM)vs › | $914.73M | $881.99M |
| QuidelOrtho Corporation (QDEL)vs › | $857.16M | $3.81B |
| Alumis Inc. (ALMS)vs › | $855.38M | $828.11M |
| MoonLake Immunotherapeutics (MLTX)vs › | $921.06M | $544.69M |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $853.13M | $832.27M |
Market Cap
$887.99M
Total Debt
$403000.00
Cash
$4.58M
Enterprise Value
$883.82M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
